A specific, accurate, and sensitive measure of total plasma malondialdehyde by HPLC.

J Lipid Res

School of Pharmacy and Life Sciences, Robert Gordon University, Schoolhill, Aberdeen, Scotland.

Published: March 2013

AI Article Synopsis

  • Malondialdehyde (MDA) is a key marker for lipid peroxidation commonly used in clinical studies, typically measured using thiobarbituric acid (TBA) assays that produce a pink color in the presence of MDA.
  • A study compared the specificity of the TBA assay (known as TBARS) with chromatographic methods for measuring plasma MDA, finding that TBARS levels were consistently higher and more variable between individuals.
  • The research highlights the inaccuracies in relying on TBARS assays for MDA quantification, suggesting that they may not accurately reflect true lipid peroxidation levels in clinical settings.

Article Abstract

Malondialdehyde (MDA) is one of the most commonly reported biomarkers of lipid peroxidation in clinical studies. The reaction of thiobarbituric acid (TBA) with MDA to yield a pink chromogen attributable to an MDA-TBA₂ adduct is a common assay approach with products being quantified by ultraviolet-Vis assay as nonspecific TBA-reactive substances (TBARS) or chromatographically as MDA. The specificity of the TBARS assay was compared with both chromatographic assays for total plasma MDA. The levels of total plasma MDA were significantly lower than the plasma TBARS in each of the samples examined, and interestingly, the interindividual variation apparent in the level of plasma MDA was not evident in the plasma TBARS assay. Each of the four online chromatographic detectors yielded a precise, sensitive, and accurate determination of total plasma MDA, and selected-ion monitoring was the most-accurate assay (101.3%, n = 4). The online diode array detectors provided good assay specificity (peak purity index of 999), sensitivity, precision, and accuracy. This research demonstrates the inaccuracy that is inherent in plasma TBARS assays, which claim to quantify MDA, and it is proposed that the TBARS approach may limit the likelihood of detecting true differences in the level of lipid peroxidation in clinical studies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617959PMC
http://dx.doi.org/10.1194/jlr.D032698DOI Listing

Publication Analysis

Top Keywords

total plasma
16
plasma mda
16
plasma tbars
12
plasma
8
mda
8
lipid peroxidation
8
peroxidation clinical
8
clinical studies
8
tbars assay
8
assay
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!